{"groups":[{"description":"MAGE-A3, GM-CSF, Hiltonol® (Poly-ICLC), PCV vaccine prior to apheresis.\n\nStem cell mobilization. High-dose melphalan, then hematopoietic stem cells on Day 0.\n\nDay 2 Activated/costimulated autologous T cells.\n\nDays 14, 42 and 90 MAGE-A3, Hiltonol® and PVC.\n\nDay 100 start Lenalidomide.\n\nDay 120 and 150 MAGE-A3 and PVC.","id":"FG000","title":"MAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"28"}],"type":"STARTED"},{"achievements":[{"comment":"One subject failed to meet screening criteria for the trial.","groupId":"FG000","numSubjects":"27"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Enrollment"},{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"27"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"27"}],"comment":"MAGE-A3, GM-CSF, Hiltonol®, PCV vaccine \\~10 days before apheresis.","type":"Pre Transplant Vaccinations 1-3"},{"achievements":[{"groupId":"FG000","numSubjects":"27"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Pre Transplant Vaccinations"},{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"27"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"27"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Activated/Costimulated Autologous T Cell"},{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Off Study due to Disease Progression"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"27"}],"comment":"On study Days 14, 42 and 90 study participants will receive MAGE-A3, Hiltonol® and PVC vaccine.","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"26"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"MAGE-A3, Hiltonol®, PVC After T Cells"},{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"26"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"26"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Start Lenalidomide"},{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"26"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"26"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Maintenance: MAGE-A3, PVC After T Cells"}]}